Aberdeen Group’s Zai Lab ZLAB Stock Holding History

Aberdeen Group’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.91M	Buy	311,294 +73,555	+31%	+$1.45M	0.01%	676
2026 Q1	$4.47M	Buy	+237,739	New	+$4.41M	0.01%	701
2023 Q2	–	Sell	-31,547	Closed	-$1.05M	–	932
2023 Q1	$1.05M	Buy	31,547 +2,967	+10%	+$114K	﹤0.01%	792
2022 Q4	$877K	Buy	28,580 +6,164	+27%	+$194K	﹤0.01%	791
2022 Q3	$767K	Buy	22,416 +3,651	+19%	+$156K	﹤0.01%	804
2022 Q2	$651K	Buy	18,765 +10,438	+125%	+$368K	﹤0.01%	833
2022 Q1	$366K	Buy	8,327 +246	+3%	+$11.9K	﹤0.01%	924
2021 Q4	$509K	Buy	8,081 +574	+8%	+$48.7K	﹤0.01%	961
2021 Q3	$791K	Buy	7,507 +316	+4%	+$45.4K	﹤0.01%	919
2021 Q2	$1.27M	Buy	7,191 +1,138	+19%	+$183K	﹤0.01%	847
2021 Q1	$808K	Buy	6,053 +1,093	+22%	+$169K	﹤0.01%	881
2020 Q4	$671K	Buy	4,960 +2,151	+77%	+$219K	﹤0.01%	861
2020 Q3	$234K	Buy	+2,809	New	+$226K	﹤0.01%	913

Other funds holding ZLAB

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aberdeen Group's ZLAB Position: Q2 2026 in Review

Aberdeen Group increased its Zai Lab (ZLAB) stake by 31% in Q2 2026, buying an estimated $1.45M and bringing the position to 311,294 shares worth $5.91M. The position accounts for 0.01% of the portfolio, ranked #676.

Aberdeen Group first reported a position in ZLAB in Q3 2020 and has held it in 13 quarters since. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

Aberdeen Group held 311,294 shares of Zai Lab worth $5.91M as of Q2 2026.
Aberdeen Group bought 73,555 Zai Lab shares in Q2 2026, an estimated $1.45M.
Zai Lab made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #676 holding.
Aberdeen Group first reported a position in Zai Lab in Q3 2020 and has held it in 13 quarters since.
93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.